Early Milestones

  • Continue R&D and get device approval for use on humans.
  • Obtain IRB & FDA agreement for a pilot and a clinical trial.
  • Complete the clinical trial in chronic diabetic foot ulcers and gain FDA device approval for diabetic foot ulcer therapy.
  • Obtain reimbursement codes for insurance and for Medicare/Medicaid.
  • Implement a sales force, distribution network, and contract manufacturer.
  • Market and sell for the treatment of diabetic foot ulcers.